| Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation L Fauchier, A Cinaud, F Brigadeau, A Lepillier, B Pierre, S Abbey, ... Journal of the American College of Cardiology 71 (14), 1528-1536, 2018 | 352 | 2018 |
| Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ... European heart journal 43 (7), e17-e25, 2022 | 212 | 2022 |
| Periprocedural myocardial infarction and injury in elective coronary stenting M Zeitouni, J Silvain, P Guedeney, M Kerneis, Y Yan, P Overtchouk, ... European heart journal 39 (13), 1100-1109, 2018 | 205 | 2018 |
| Antithrombotic therapy for patients with left ventricular mural thrombus B Lattuca, N Bouziri, M Kerneis, JJ Portal, J Zhou, M Hauguel-Moreau, ... Journal of the American College of Cardiology 75 (14), 1676-1685, 2020 | 194 | 2020 |
| Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions DN Kalkman, M Aquino, BE Claessen, U Baber, P Guedeney, ... European heart journal 39 (46), 4101-4108, 2018 | 124 | 2018 |
| Coronary calcification and long-term outcomes according to drug-eluting stent generation P Guedeney, BE Claessen, R Mehran, GS Mintz, M Liu, S Sorrentino, ... Cardiovascular Interventions 13 (12), 1417-1428, 2020 | 119 | 2020 |
| Long-term mortality and early valve dysfunction according to anticoagulation use: the FRANCE TAVI registry P Overtchouk, P Guedeney, S Rouanet, JP Verhoye, T Lefevre, ... Journal of the American College of Cardiology 73 (1), 13-21, 2019 | 112 | 2019 |
| Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial J Silvain, B Lattuca, F Beygui, G Rangé, Z Motovska, JG Dillinger, ... The Lancet 396 (10264), 1737-1744, 2020 | 110 | 2020 |
| Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention P Guedeney, BE Claessen, DN Kalkman, M Aquino, S Sorrentino, ... Journal of the American College of Cardiology 73 (19), 2401-2409, 2019 | 100 | 2019 |
| Antithrombotic therapy after transcatheter aortic valve replacement P Guedeney, R Mehran, JP Collet, BE Claessen, J Ten Berg, GD Dangas Circulation: Cardiovascular Interventions 12 (1), e007411, 2019 | 88 | 2019 |
| Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry A Sedaghat, V Vij, B Al-Kassou, S Gloekler, R Galea, M Fürholz, B Meier, ... Circulation: Cardiovascular Interventions 14 (5), e010195, 2021 | 83 | 2021 |
| Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention J Silvain, LS Nguyen, V Spagnoli, M Kerneis, P Guedeney, N Vignolles, ... Heart 104 (9), 767-772, 2018 | 73 | 2018 |
| Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis P Guedeney, S Sorrentino, G Giustino, C Chapelle, S Laporte, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (3), 225-235, 2021 | 54 | 2021 |
| Lipid management in patients presenting with acute coronary syndromes: a review BE Claessen, P Guedeney, CM Gibson, DJ Angiolillo, D Cao, N Lepor, ... Journal of the American Heart Association 9 (24), e018897, 2020 | 50 | 2020 |
| Apixaban and valve thrombosis after transcatheter aortic valve replacement: the ATLANTIS-4D-CT randomized clinical trial substudy G Montalescot, A Redheuil, F Vincent, S Desch, M De Benedictis, ... Cardiovascular Interventions 15 (18), 1794-1804, 2022 | 46 | 2022 |
| Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: a post hoc analysis from the BRAVO‐3 randomized trial D Power, U Schäfer, P Guedeney, BE Claessen, S Sartori, S Sorrentino, ... Catheterization and Cardiovascular Interventions 93 (7), 1374-1381, 2019 | 46 | 2019 |
| Supraventricular arrhythmia following patent foramen ovale percutaneous closure P Guedeney, M Laredo, M Zeitouni, M Hauguel-Moreau, T Wallet, ... Cardiovascular Interventions 15 (22), 2315-2322, 2022 | 40 | 2022 |
| Bleeding risk, dual antiplatelet therapy cessation, and adverse events after percutaneous coronary intervention: the PARIS registry S Sorrentino, S Sartori, U Baber, BE Claessen, G Giustino, ... Circulation: Cardiovascular Interventions 13 (4), e008226, 2020 | 38 | 2020 |
| Diagnosis and management of acute coronary syndrome: what is new and why? insight from the 2020 european society of cardiology guidelines P Guedeney, JP Collet Journal of Clinical Medicine 9 (11), 3474, 2020 | 36 | 2020 |
| Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events A Alperi, P Guedeney, E Horlick, L Nombela-Franco, X Freixa, I Pascual, ... Circulation: Cardiovascular Interventions 15 (7), e011652, 2022 | 35 | 2022 |
Gilles MontalescotProfesseur de CardiologieVerified email at aphp.fr
